
Dutch cancer patients forced to wait for drug pricing dispute resolution
Dutch cancer patients have been denied access to two drugs after the Dutch Healthcare Institute claimed the drug manufacturers did not provide the information necessary to determine whether the drugs were worth their asking price. One of the pharmaceutical …